Ware Discusses with Reuters the Future of Non-Disclosure Agreements in Sexual Harassment and Misconduct Cases
December 19, 2017
Reuters
Of Counsel Dabney Ware told Reuters in the article “Sexual Misconduct Outcry Makes U.S. Lawyers Rethink Confidentiality” that non-disclosure agreements will likely be on the wane in workplace sexual harassment settlements and that future confidentiality agreements might cover only the names of the parties and the amount paid in the settlement, while allowing allegations to be made public.
Ware said she expects non-disclosure agreements to continue to be used in less egregious cases, or when investigations into harassment claims are inconclusive. “We’re still going to have places where it seems appropriate to keep things confidential, but it’s going to be a lot more limited,” she said.
Ware said she expects non-disclosure agreements to continue to be used in less egregious cases, or when investigations into harassment claims are inconclusive. “We’re still going to have places where it seems appropriate to keep things confidential, but it’s going to be a lot more limited,” she said.
Related News
July 24, 2025
In the News
Foley's Trial Team Featured Following Landmark Victory in Texas Trade Secret Case
Foley & Lardner LLP’s recent landmark appellate victory in a Texas trade secrets case is featured in the Texas Lawyer article, "Ruling Sets Precedent for Employment, Trade Secrets, Fiduciary Duty."
July 24, 2025
In the News
Gregory Husisian and David Simon on Tariff Evasion – 'Huge money at stake'
Foley & Lardner LLP partners Gregory Husisian and David Simon detailed the rise and risks of tariff evasion in the POLITICO article, "As Trump raises tariffs, companies find ways to cheat — and risk getting caught."
July 23, 2025
In the News
Aaron Maguregui on AI Scribes in Health Care – 'Technically, it's a third party listening'
Foley & Lardner LLP partner Aaron Maguregui shared insights on the growing applications for artificial intelligence across health care in the healthleaders article, “Is Your AI Scribe HIPAA-Compliant?“